| Dr Jorge M Diduszyn, MD | |
|
840 5th Ave, Chambersburg, PA 17201-4219 | |
| (717) 264-5433 | |
| (717) 264-3784 |
| Full Name | Dr Jorge M Diduszyn |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Geriatric Medicine |
| Location | 840 5th Ave, Chambersburg, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073574257 | NPI | - | NPPES |
| 001809814 | Other | PA | HIGHMARK BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MD427818 (Pennsylvania) | Secondary |
| 207RG0300X | Internal Medicine - Geriatric Medicine | MD427818 (Pennsylvania) | Primary |
| Entity Name | Pinnacle Health Medical Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932143427 PECOS PAC ID: 7618960493 Enrollment ID: O20040407000180 |
News Archive
In a newly published, pilot study in the journal Ethnicity & Disease, researchers report a relatively low prevalence of vascular risk among participants of the Southwest Heart Mind Study, especially among those treated for hypertension and hyperlipidemia despite overweight and obesity.
Research out on the pre-publication website medRxiv shows how non-pharmaceutical interventions (NPIs) like mask wearing and physical distancing can help prevent spikes in COVID-19 cases as populations continue to get vaccinated.
Children who undergo surgery for congenital heart disease have lower survival rates by three years of age if there are specific problems during fetal development, such as hypertension in the mother or the newborn being born preterm or small for gestational age.
In a new effort to eliminate harm and reinforce a culture of caring in healthcare, Johns Hopkins School of Nursing faculty members Ellen Ray, DNP, MS, RN, CNM, Cynthia Foronda, PhD, RN, CNE, and Brigit Van Graafeiland, DNP, CNRP, have been chosen to serve in the third cohort of the Johns Hopkins Armstrong Institute Patient Safety and Quality Leadership Academy.
CeNeRx BioPharma, Inc., a clinical-stage company developing and commercializing innovative treatments for diseases of the central nervous system (CNS), today announced FDA approval of its IND and reported the first clinical results in humans for CXB909, a novel agent that has demonstrated utility in preclinical models of neuroprotection and neurodegenerative disorders.
› Verified 8 days ago
| Entity Name | Albright Care Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902932007 PECOS PAC ID: 5991875015 Enrollment ID: O20080602000476 |
News Archive
In a newly published, pilot study in the journal Ethnicity & Disease, researchers report a relatively low prevalence of vascular risk among participants of the Southwest Heart Mind Study, especially among those treated for hypertension and hyperlipidemia despite overweight and obesity.
Research out on the pre-publication website medRxiv shows how non-pharmaceutical interventions (NPIs) like mask wearing and physical distancing can help prevent spikes in COVID-19 cases as populations continue to get vaccinated.
Children who undergo surgery for congenital heart disease have lower survival rates by three years of age if there are specific problems during fetal development, such as hypertension in the mother or the newborn being born preterm or small for gestational age.
In a new effort to eliminate harm and reinforce a culture of caring in healthcare, Johns Hopkins School of Nursing faculty members Ellen Ray, DNP, MS, RN, CNM, Cynthia Foronda, PhD, RN, CNE, and Brigit Van Graafeiland, DNP, CNRP, have been chosen to serve in the third cohort of the Johns Hopkins Armstrong Institute Patient Safety and Quality Leadership Academy.
CeNeRx BioPharma, Inc., a clinical-stage company developing and commercializing innovative treatments for diseases of the central nervous system (CNS), today announced FDA approval of its IND and reported the first clinical results in humans for CXB909, a novel agent that has demonstrated utility in preclinical models of neuroprotection and neurodegenerative disorders.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jorge M Diduszyn, MD 840 5th Ave, Chambersburg, PA 17201-4219 Ph: (717) 264-5433 | Dr Jorge M Diduszyn, MD 840 5th Ave, Chambersburg, PA 17201-4219 Ph: (717) 264-5433 |
News Archive
In a newly published, pilot study in the journal Ethnicity & Disease, researchers report a relatively low prevalence of vascular risk among participants of the Southwest Heart Mind Study, especially among those treated for hypertension and hyperlipidemia despite overweight and obesity.
Research out on the pre-publication website medRxiv shows how non-pharmaceutical interventions (NPIs) like mask wearing and physical distancing can help prevent spikes in COVID-19 cases as populations continue to get vaccinated.
Children who undergo surgery for congenital heart disease have lower survival rates by three years of age if there are specific problems during fetal development, such as hypertension in the mother or the newborn being born preterm or small for gestational age.
In a new effort to eliminate harm and reinforce a culture of caring in healthcare, Johns Hopkins School of Nursing faculty members Ellen Ray, DNP, MS, RN, CNM, Cynthia Foronda, PhD, RN, CNE, and Brigit Van Graafeiland, DNP, CNRP, have been chosen to serve in the third cohort of the Johns Hopkins Armstrong Institute Patient Safety and Quality Leadership Academy.
CeNeRx BioPharma, Inc., a clinical-stage company developing and commercializing innovative treatments for diseases of the central nervous system (CNS), today announced FDA approval of its IND and reported the first clinical results in humans for CXB909, a novel agent that has demonstrated utility in preclinical models of neuroprotection and neurodegenerative disorders.
› Verified 8 days ago
Ryan R Gaffney, DO Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 835 5th Ave, Chambersburg, PA 17201 Phone: 717-263-0629 Fax: 717-263-7105 | |
Saba Memon, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 112 N 7th St, Chambersburg, PA 17201 Phone: 717-217-4300 | |
Dr. Farshad Sepahpanah, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 112 N 7th St, Chambersburg, PA 17201 Phone: 717-217-4300 Fax: 717-217-4399 | |
Ryan M Decort, DO Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 2055 Scotland Ave, Chambersburg, PA 17201 Phone: 717-217-6055 Fax: 717-217-4329 | |
Gohar Arslan, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 22 St Paul Dr, Chambersburg, PA 17201 Phone: 717-217-6020 Fax: 717-217-6939 | |
Louis E Coda, MD Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 112 N 7th St, Chambersburg, PA 17201 Phone: 717-262-4546 Fax: 717-263-1146 | |
Awais Ammar, MD Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 20 Parkwood Dr Ste 2, Chambersburg, PA 17201 Phone: 717-263-7757 |